About Index Trending news
Analyze
Top 50 Pricing
Delinia

Delinia

Work at Delinia? Add yourself to this profile

Delinia

Delinia aims to discover and develop novel therapeutics targeting regulatory T cells for the treatment of autoimmune and inflammatory diseases

Elsewhere

Alexa global traffic share

Twitter followers

14 Sep 2016
$35,000,000
Venture capital (Series A)

Delinia Announces $35 Million Series A Financing to Advance Novel Therapeutics Targeting Regulatory T Cells for Autoimmune Diseases | Business Wire

businesswire
+1